Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial

PURPOSE: Pancreatic cancer is rapidly fatal with median survival of only 6 months (mo). Quality-of-life (QoL) was analyzed prospectively in a phase 2 study of gemcitabine (G), capecitabine (C) and bevacizumab (B) in APC patients. METHODS: A total of 50 patients with APC received B 15 mg/kg, C 1,300...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Gastrointest Oncol
Main Authors: Anwar, Sidra, Tan, Wei, Yu, Jinhee, Hutson, Alan, Javle, Milind, Iyer, Renuka
Format: Artigo
Sprog:Inglês
Udgivet: Pioneer Bioscience Publishing Company 2014
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226818/
https://ncbi.nlm.nih.gov/pubmed/25436122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.070
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker